Genix Pharmaceuticals Corporation Receives Natural Product Number for Rechlor from Health Canada

Genix Pharmaceuticals Corp. Receives Approval for Drug Establishment License

Genix Pharmaceuticals Corp. Lists on the OTCQB Venture Market Exchange

Genix Pharmaceuticals Corporation Provides a Corporate Update To Shareholders

Genix Pharmaceuticals Corp. Announces AGM Results and Appoints Mahmoud Aziz to the Board and as President

Genix Pharmaceuticals Corporation Enters into Exclusive License and Supply Agreement for Canada’s First Generic Thyroid Medication

Genix Pharmaceuticals Corporation prepares to file Abbreviated New Drug Submissions (ANDS) for its first ten Ophthalmic Drugs with Health Canada

Genix Pharmaceuticals Corporation Announces Appointment of New Chief Financial Officer

Genix Pharmaceuticals Corporation Announces AGM Results and Welcomes New Director

Genix Pharmaceuticals Corporation Announces Closing of Second Tranche Financing and closing of acquisition of rights to Nutraceutical Products Sucanon® and Renochlor®